Apheresis Equipment Market is expected to reach US$ 3,854.77 million in 2028


PRESS RELEASE BY The Insight Partners 16 Oct 2019

Share this press on


The global apheresis equipment market is expected to reach US$  3,854.77 million in 2028; registering at a CAGR of 8.0% from 2022 to 2028, according to a new research study conducted by The Insight Partners

LDL-Apheresis Segment to Account for Largest Share of Apheresis Equipment Market during 2021-2028

The report highlights the key factors driving the market growth and prominent players with their developments in the market. The growth of the apheresis equipment market is primarily attributed to increasing number of voluntary blood donors, rising incidence of hematologic diseases, and growing geriatric population. However, the factors such as high cost of apheresis equipment and complications associated with apheresis procedure are hampering the market growth. Moreover, the rising usage of the apheresis technique in emerging economies is likely to provide a lucrative opportunity for the market growth.

Apheresis Equipment Market, by Geography, 2021 (%)

Source: The Insight Partners Analysis

Based on procedure, the global apheresis equipment market is segmented into plasmapheresis, photopheresis, erythrocytapheresis, leukapheresis, plateletpheresis, and LDL-apheresis. In 2021, the plasmapheresis segment held the largest share of the market. Moreover, the LDL-apheresis segment is expected to grow at the fastest rate in the coming years owing to the increasing incidence of cardiovascular disorders among the global population. The LDL-apheresis treatment can lower LDL cholesterol and LP(a) by 60-75%, thus improving cholesterol levels.

Based on therapeutic area, the global apheresis equipment market is segmented into hematology, renal diseases, neurology, and other therapeutic areas. Based on end user, the global apheresis equipment market is segmented into blood banks/ blood donation centers, hospitals & clinics, and ambulatory surgical centers. Based on technology, the market is bifurcated into centrifugation and membrane separation. Based on product, the market is bifurcated into disposable apheresis kits and apheresis machine.

Based on region, the global apheresis equipment market is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. The Europe apheresis equipment market is segmented into Germany, the UK, France, Italy, and Spain. The market growth is contributed by the rising number of people opting for apheresis procedures to treat therapeutic conditions in European countries, such as Germany and the UK. Also, there is increased blood donation in the countries.

Further, the rising regulations on the use of blood-derived products in European countries such as France, Italy, and Spain are likely to create growth opportunities for the apheresis market. Also, the rising healthcare expenditure is likely to fuel the market growth significantly during the forecast period.

A few of the major players operating in the apheresis equipment market are Medica SPA; Terumo Corporation; B. Braun Melsungen AG; Fresenius Medical Care AG & Co. KGaA; Asahi Kasei Corporation; Haemonetics Corporation; HemaCare Corporation; KANEKA MEDIX CORPORATION; Kawasumi Laboratories, Inc.; and Medicap Clinic GmbH. 

By geography, the global apheresis equipment market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South & Central America).

Contact Us
 
Phone: +1-646-491-9876
Email Id: sales@theinsightpartners.com

Download Free PDF Brochure